ALAS1 and cancer: This system does not appear to be limited to colorectal cancer alone, as analyses on the BioXpress database [80] revealed that heightened FLVCR1a expression is a common characteristic across various types of cancer [27], and increased ALAS1-mediated heme biosynthesis is a recognized metabolic dependency in different kinds of tumors [11, 81, 82].